ARCHIVES

New Chemotherapy, Other Modality Progress Described

This article is from The Cancer Letter archive.

Vol. 05 No. 13 | March 30, 1979

Download PDF Visit The Full Archive

Related Articles

Administration To Hold ASSIST Funding To ’92 Level; ACS Says Result Is Percent Cut

March 20, 1992

Zometa Prevents Bone Loss In Premenopausal Women

August 29, 2008

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Other Agencies Offer Advice; No Money For Oncology Nurse Training

February 24, 1978

Feinstein Reintroduces New National Cancer Act

June 13, 2003

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

June 23, 1995